BPC-157 vs TB-500 — Repair Peptides Compared for Preclinical Research

BPC-157 and TB-500 are the two most frequently compared repair peptides in preclinical research, and the clearest difference is their origin: BPC-157 is a synthetic pentadecapeptide, while TB-500 is a fragment of the naturally occurring protein thymosin beta-4. They are often grouped together because both appear in tissue-repair and recovery studies, but their biochemical profiles are not interchangeable.

I have watched labs default to buying both at once without first understanding which one fits the model they are running. The better approach is to match the peptide to the specific tissue or injury model in your protocol, not to the popularity of the name.

Origin and Mechanism

BPC-157 is a 15-amino-acid peptide derived from a protective protein found in gastric juice, while TB-500 is a synthetic fragment of thymosin beta-4, a protein involved in actin regulation and cell migration.

  • BPC-157 — pentadecapeptide; studied for angiogenic and tissue-repair signaling in a wide range of preclinical models.
  • TB-500 — thymosin beta-4 fragment; studied for cell migration, actin regulation, and wound-healing pathways.

Because their origins and targets differ, the two are frequently used in different experimental contexts rather than as direct substitutes.

Stability and Handling

Both peptides are lyophilized for long-term storage at -20°C, but TB-500 is generally regarded as more stable in solution once reconstituted. Confirm with your supplier how long a reconstituted vial remains usable under refrigeration.

AttributeBPC-157TB-500
OriginSynthetic 15-AA peptideThymosin beta-4 fragment
Primary research focusAngiogenesis, tissue repair signalingCell migration, actin regulation
Typical purity standard≥98% HPLC≥98% HPLC
Solution stabilityModerateGenerally higher

Which One Fits Your Protocol?

The deciding factor is usually the tissue or pathway your study targets, not cost — both are similarly priced at research scale. If your model focuses on angiogenesis or mucosal repair, BPC-157 is the more common choice in the literature. If your model centers on cell migration or wound closure, TB-500 is the more frequent reference compound.

FAQ

Are BPC-157 and TB-500 interchangeable?

No — they have different origins, different amino acid sequences, and different primary research contexts, so they should not be treated as direct substitutes. Match the peptide to the specific model in your protocol.

What purity should I look for in BPC-157 and TB-500?

Both should meet ≥98% purity by HPLC with a batch-specific COA that includes a mass spectrometry confirmation. This is the minimum bar for research-grade material.

How should these peptides be stored after delivery?

Store lyophilized vials at -20°C for long-term stability, and keep reconstituted solution refrigerated, using it within the supplier’s stated window. Vacuum-sealed, inert-gas packaging extends shelf life.

Can I order both from the same wholesale supplier?

Yes — reputable research peptide suppliers carry both, and ordering them together from one COA-backed source is the most efficient way to keep documentation consistent.

Contact Our Research Team

For batch-specific COA documents, bulk pricing, or current stock availability, reach us on WhatsApp (+852 4419 8097) or browse the full catalog at tb500.pro.

Important: All products are sold strictly for laboratory and research purposes only — not for human or veterinary use. No medical or dosing guidance is provided.

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart
Need help?